Abstract
Treatment of aqueductal stenosis (AQS) has undergone several paradigm shifts during the past decades. Currently, endoscopic ventriculostomy (ETV) is recommended as treatment of choice. Several authors have addressed the issue of variable ETV success rates depending on age and pathogenetic factors. However, success rates have usually been defined as “ETV non-failure.” The aim of the study was a retrospective analysis of radiological and neurological treatment response after ETV or VP-shunting (VPS) in age-dependent subtypes of AQS.
Patients and methods
Eighty patients (median age 12.0 years, range 0–79 years) have been treated for MRI-proven aqueductal stenosis. Neurological treatment success was defined by neurological improvement and, in childhood, head circumference. Radiological response was measured as Evan’s index in follow-up MRI. Initial signs and symptoms, type of surgery, and complications were analyzed.
Results
Four types of AQS have been defined with distinct age ranges and symptomatology: congenital type I (n = 24), chronic progressive (tectal tumor-like) type II (n = 23), acute type III (n = 10), and adult chronic (normal-pressure hydrocephalus-like) type IV (n = 23). Retrospective analysis of neurological and radiological outcome suggested that congenital type I (<1 years of age) may be more successfully treated with VPS than with ETV (81 vs. 50 %). Treatment of chronic juvenile type II (age 2–15) by ETV 19 % compared to 57 % after VP-shunt, but similar neurological improvement (>80 %). There has been no influence of persistent ventriculomegaly in type II after ETV in contrast to VPS therapy for neurological outcome. Adult acute type III (age > 15 years) responded excellent to ETV. Chronic type IV (iNPH-like) patients (age > 21) responded neurologically in 70 % after ETV and VPS, but radiological response was low (5 %).
Conclusion
AQS can be divided into four distinct age groups and types in regards of clinical course and symptomatology. Depending on the AQS type, ETV cannot be unequivocally recommended. Congenital type I AQS may have a better neurological outcome with VP-shunt whereas acute type III offers excellent ETV results. Chronic progressive type II still requires prospective investigation of long-term ETV outcome, especially when ventriculomegaly persists. Late chronic type IV seems to result in similar outcome after VP-shunt and ETV.
Similar content being viewed by others
References
Alksne JF, Brahl G, Bradley WG Jr (2006) Idiopathic normal pressure hydrocephalus may be a “two hit” disease: benign external hydrocephalus in infancy followed by deep white matter ischemia in late adulthood. J Magn Reson Imaging 24(4):747–755
Eichenwald HF. A study of congenital toxoplasmosis with particular emphasis on clinical manifestations, sequelae and therapy. In: Human Toxoplasmosis, Siim JC (Ed), Munksgaard, Copenhagen 1959.
Fountas KN, Kapsalaki EZ, Paterakis KN, Lee GP, Hadjigeorgiou GM (2012) Role of endoscopic third ventriculostomy in treatment of selected patients with normal pressure hydrocephalus. Acta Neurochir Suppl. 113:129–133
Garcia LG, Lopez BR, Botella GI, Paez MD, da Rosa SP, Ruis F, Sanchez MA (2012) Endoscopic third ventriculostomy success score (ETVSS) predicting success in a series of 50 pediatric patients. are the outcomes predictable? Childs Nerv Syst 28(8):1157–1162
Kiefer M, Eymann R, Komenda Y, Steudel WI (2003) A grading system for chronic hydrocephalus. Zentralbl Neurochir 64:109–115
Kiefer M, Eymann R, Steudel WI, Strowitzki M (2005) Gravitational shunt management of long-standing overt ventriculomegaly in adult (LOVA). J Clin Neurosci 12(1):21–26
Kiefer M, Eymann R, Steudel WI (2002) German [LOVA hydrocephalus—a new entity of chronic hydrocephalus]. Nervenarzt 73(10):972–981
Kulkarni AV, Drake JM, Kestle JR, Mallucci CL, Sgouros S, Constantini S (2010) Canadian Pediatric Neurosurgery Study Group. Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score. J Neurosurg Pediatr 6(4):310–315
Kulkarni AV, Riva-Cambrin J, Browd SR (2011) Use of the ETV Success score to explain the variation in reported endoscopic third ventriculostomy success rates among published case series in childhood hydrocephalus. J Neurosurg Pediatr 7(2):143–146
Laurence KM, Coates S (1962) The natural history of hydrocephalus. Detailed analysis of 182 unoperated cases. Arch Dis Child 37:345–362
Limbrick DD, Baird LC, Klima P Jr, Riva-Cambrin J, Flannery AM (2014) Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. part 4: cerebrospinal fluid shunt or endoscopic third ventriculostomy for the treatment of hydrocephalus in children. J Neurosurg Pediatrics 14(Suppl):30–34
Mandell JG, Kulkarni AV, Warf BC, Schiff SJ (2015) Volumetric brain analysis in neurosurgery. Part 2. Brain and CSF volumes discriminate neurocognitive outcomes in hydrocephalus. J Neurosurg Pediatr 15(2):125–132
Mandell JG, Langelaan JW, Webb AG, Schiff SJ (2015) Volumetric brain analysis in neurosurgery. Part 1. Particle filter segmentation of brain and cerebrospinal fluid growth dynamics from MRI and CT images. J Neurosurg Pediatr 15(2):113–124
Nikas DC, Post AF, Choudhri AF, Mazolla CA, Michtell L, Flannery AM (2014) Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. part 10: change in ventricle size as a measurement of effective treatment of hydrocephalus. J Neurosurg Pediatrics (Suppl) 14:77–81
Paidakakos N, Borgarello S, Naddeo M (2012) Indications for endoscopic third ventriculostomy in normal pressure hydrocephalus. Acta Neurochir Suppl. 113:123–127
Preuß M, Kutscher A, Wachowiak R, Merkenschlager A, Bernhard MK, Reiss-Zimmermann M, Meixensberger J, Nestler U (2015) Adult long-term outcome of patients after congenital hydrocephalus shunt therapy. Childs Nerv Syst 31(1):49–56
Preuß M, Hoffmann KT, Reiss-Zimmermann M, Merkenschlager A, Meixensberger J, Dengl M (1811-1825) Updated physiology and pathophysiology of CSF circulation—the pulsatile vector theory. Childs Nerv System 29(7):2013 Review
Rekate HL (2007) Longstanding overt ventriculomegaly in adults: pitfalls in treatment with endoscopic third ventriculostomy. Neurosurg Focus 22(4):E6
Sari E, Sari S, Akgün V, Özcan E, Ìnce S, Babacan O, Saldir M, Acikel C, Basbozkurt G, Yesilkaya S, Kilic C, Vurucu S, Kocaoglu M, Yesilkaya E (2015) Measures of ventricles and Evans’ Index: from neonate to adolescent. Pediatr Neurosurg Jan 22
Schuhmann MU, Sood S, McAllister JP, Jaeger M, Ham SD, Czosnyka Z, Czosnyka M (2008) Value of overnight monitoring of intracranial pressure in hydrocephalic children. Pediatr Neurosurg 44(4):269–279
Spennato P, Tazi S, Bekaert O, Cinalli G, Decq P (2013) Endoscopic third ventriculostomy for idiopathic aqueductal stenosis. World Neurosurgery 79(2 Suppl):S21 e13–20
Vinchon M, Baroncini M, Delestret I (2012) Adult outcome of pediatric hydrocephalus. Childs Nerv Syst 28(6):847–854
Zandian A, Haffner M, Johnson J, Rozzelle CJ, Tubbs RS, Loukas M (2014 Apr) Endoscopic third ventriculostomy with/without choroid plexus cauterization for hydrocephalus due to hemorrhage, infection, Dandy-Walker malformation, and neural tube defect: a meta-analysis. Childs Nerv Syst 30(4):571–578. doi:10.1007/s00381-013-2344-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests for the presented study.
Rights and permissions
About this article
Cite this article
Rodis, I., Mahr, C.V., Fehrenbach, M.K. et al. Hydrocephalus in aqueductal stenosis—a retrospective outcome analysis and proposal of subtype classification. Childs Nerv Syst 32, 617–627 (2016). https://doi.org/10.1007/s00381-016-3029-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-016-3029-y